
Experts Identify Six Short-Term Stocks for Potential Gains
Market Benchmark Nifty 50 Records Weakest Performance Since COVID-Hit FY20
The Indian stock market has been under pressure in recent months, with the market benchmark Nifty 50 dropping more than 11% in March, marking its weakest performance since the COVID-hit financial year 2020. The financial year 2025-26 (FY26) ended with a loss of 5%, a decline from the previous year. On Monday, March 30, the Sensex crashed 1,636 points, or 2.22%, to end at 71,947.55, while the Nifty 50 declined 488 points, or 2.14%, to finish at 22,331.40.
The market is facing elevated crude oil prices driven by the West Asian war, a record-low rupee, and massive foreign capital outflow, all of which are keeping the market under pressure. Market experts say the near-term outlook is clouded with uncertainty and recommend maintaining prudence while picking stocks.
Recommended Stocks for the Short Term
Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data
Two market experts, Hitesh Tailor of Choice Broking and Vishnu Kant Upadhyay of Master Capital Services, have recommended the following six stocks to buy for the next 1-2 weeks.
| Stock | Previous Close | Target Price | Stop Loss |
|---|---|---|---|
| Avenue Supermarts (DMart) | ₹3,956.80 | ₹4,250 | ₹3,800 |
| Multi Commodity Exchange of India (MCX) | ₹2,389.40 | ₹2,600 | ₹2,280 |
| Aurobindo Pharma | ₹1,304.40 | ₹1,425 | ₹1,230 |
| Emcure Pharmaceuticals | ₹1,595.50 | ₹1,705 and ₹1,740 | ₹1,490 |
| Godawari Power And Ispat (GPIL) | ₹268.80 | ₹290 and ₹300 | ₹250 |
| NLC India | ₹268.60 | ₹288 and ₹296 | ₹251 |
Here are the details of the stock recommendations:
- Avenue Supermarts (DMart): Hitesh Tailor recommends buying at the current market price with a stop loss at ₹3,800 for a target of ₹4,250.
- Multi Commodity Exchange of India (MCX): Hitesh Tailor recommends buying at the current market price with a stop loss at ₹2,280 for a target of ₹2,600.
- Aurobindo Pharma: Hitesh Tailor recommends buying at the current market price with a stop loss at ₹1,230 for a target of ₹1,425.
- Emcure Pharmaceuticals: Vishnu Kant Upadhyay recommends buying at the current market price with a target of ₹1,705 and ₹1,740 and a stop loss at ₹1,490.
- Godawari Power And Ispat (GPIL): Vishnu Kant Upadhyay recommends buying at the current market price with a target of ₹290 and ₹300 and a stop loss at ₹250.
- NLC India: Vishnu Kant Upadhyay recommends buying at the current market price with a target of ₹288 and ₹296 and a stop loss at ₹251.
Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline
The experts have highlighted the technical structure of each stock, including signs of accumulation, breakout patterns, and momentum indicators, to support their recommendations.
Investor Takeaway
Maintain prudence while picking stocks for the short term.
More in Market

Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Indian Stocks to Watch: BHEL, Agarwal Industrial, JBM Auto, Rajesh Exports, Indian Energy Exchange, Lenskart Solutions in Market Focus on June 4.
